April 18, 2024
Stocks & Bonds
[STOCK WATCH] Pharma Research Products rises 1.91%
[THE INVESTOR] As of Feb. 15 09:10 A.M., Pharma Research Products increased 1.91%, compared with yesterday, to 37,300 won. It had declined 5.69% through the past month. Standard deviation, the variableness index, was 1.9% on the same period over one month.
Compared with its close competitors within the same industry, KOSDAQ, Pharma Research Products was not only the most satisfactory in investment return among its peer group, but its volatility was also the lowest. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -2.9%. The return-on-risk is much better than the industrial mean, -3.4, and thus the industrial comparison performance was positive.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
Compared with its close competitors within the same industry, KOSDAQ, Pharma Research Products was not only the most satisfactory in investment return among its peer group, but its volatility was also the lowest. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -2.9%. The return-on-risk is much better than the industrial mean, -3.4, and thus the industrial comparison performance was positive.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
